Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients have?
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients has 21 citations in the OpenAlex counts ScholarIQ stores.
When was Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients published?
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients has 2017 year in the ScholarIQ index.
What is the open-access status of Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients?
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients has gold oa status in the ScholarIQ index.
What is the DOI of Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients?
The DOI for Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients is on the source record.
What is the PMID of Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients?
The PMID for Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients is on the source record.
What is the OpenAlex record for Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients?
The OpenAlex for Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients is on the source record.